Latest Breaking News On - Prem premsrirut - Page 2 : comparemela.com

Mirimus, Inc Forms Strategic Collaboration with Biogen to Develop RNAi-Based Therapeutics for Neurological Disease Indications

Mirimus, Inc Forms Strategic Collaboration with Biogen to Develop RNAi-Based Therapeutics for Neurological Disease Indications
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Johanna bennett ingrid mezoPrem premsrirutMirimus incPrnewswire mirimus incBiogen incபயோஜென் இன்க்

Mirimus, Inc Partners with St John s Athletics to Enable COVID-19 Surveillance Testing of Student Athletes Using Pioneering SalivaClear Pooled Testing Platform

Share this article Share this article NEW YORK, April 20, 2021 /PRNewswire/ Mirimus, Inc., a leader in conducting high-volume, high-quality PCR testing, today announced that since November 2020 it has worked with St. John s University, a coeducational Catholic and Vincentian university in New York, to conduct rigorous COVID-19 surveillance testing of student athletes using its pioneering SalivaClear COVID-19 pooled saliva testing platform. The SalivaClear platform consists of three key elements – saliva-based sampling, pooled testing and gold-standard PCR molecular diagnostics – that, when combined, enable frequent, high-quality, high-throughput, low-cost detection of SARS-CoV-2, the virus that causes COVID-19. Mirimus SalivaClear COVID-19 Pool Testing St. John s initiated its COVID-19 surveillance program on June 26, 2020 and tests all 300+ student-athletes participating in the university s athletic program, which includes 17 sports, as well as coaches and staff, at least

New yorkUnited statesJohn diffleyJohanna bennett ingrid mezoPrem premsrirutThermofisherscientific taqpathJill christensenMirimus incJohn universityYork teamSurveillance testing program for asymptomaticDeputy athleticSports medicineSurveillance testing programUse authorized thermofisherscientificRed storm

Mirimus Named A Winner in $6M XPRIZE Rapid COVID Testing Competition

Mirimus Named A Winner in $6M XPRIZE Rapid COVID Testing Competition Mirimus one of five finalists from the main track eligible to receive $1 million Pioneering SalivaClear pooled testing platform is designed to provide frequent, high-quality, low-cost detection of SARS-CoV-2, the virus that causes COVID-19 News provided by Share this article Share this article NEW YORK, March 16, 2021 /PRNewswire/ Mirimus, Inc., a leader in conducting high-volume, high-quality PCR testing, today announced it has been named as one of five winners in XPRIZE Rapid COVID Testing for its pioneering SalivaClear ™ COVID-19 pooled saliva testing platform. The SalivaClear platform is composed of three key elements – saliva-based sampling, pooled testing and gold-standard PCR molecular diagnostics – that, when combined, enable frequent, high-quality, high-throughput, low-cost detection of SARS-CoV-2, the virus that causes COVID-19.

Prem premsrirutIngrid mezoJohanna bennettMirimus incSurveillance testing program for asymptomaticSurveillance testing programNext billionNext gen mask challengeஜோஹன்னா பென்னட்கண்காணிப்பு சோதனை ப்ரோக்ர்யாம்அடுத்தது பில்லியன்அடுத்தது கேன் முகமூடி சவால்

Mirimus, Inc Partners with Eckerd College to Enable COVID-19 Surveillance Testing of Staff and Students Using Pioneering SalivaClear Testing Platform

Share this article Share this article NEW YORK, March 8, 2021 /PRNewswire/ Mirimus, Inc., a leader in conducting high-volume, high-quality PCR testing, today announced a partnership with Eckerd College, a private, coeducational college of liberal arts and sciences in St. Petersburg, Fla., to enable weekly COVID-19 surveillance testing of faculty, staff and students using its pioneering SalivaClear COVID-19 pooled saliva testing platform. The SalivaClear platform consists of three key elements – saliva-based sampling, pooled testing and gold-standard PCR molecular diagnostics – that, when combined, enable frequent, high-quality, high-throughput, low-cost detection of SARS-CoV-2, the virus that causes COVID-19. Mirimus, Inc Eckerd initiated its COVID-19 surveillance program in Fall 2020 and ramped up testing the week of January 4, 2021 in conjunction with the start of the Winter Term. Under the first phase of the Winter program, Eckerd began by testing 50% of its 1,800 stud

Eckerd collegeUnited statesSankt peterburgJohanna bennett ingrid mezoRobbyn hopewallPrem premsrirutThermofisherscientific taqpathPhi beta kappaEckerd leadership development institutePublic relations at eckerd collegeOsher lifelong learning instituteMirimus incAcademy of senior professionalsSurveillance testing program for asymptomaticPresbyterian church united statesPublic relations

Testing remains important even as Minnesotans get vaccinated

Copy shortlink: Each week, more than 500 people make their way to Weyerhaeuser Hall on the Macalester College campus in St. Paul, where they swab the insides of their lower nostrils under medical supervision to get tested for COVID-19. The students and employees, selected semi-randomly by a computer to provide nasal samples for COVID testing, have no symptoms of the disease and no reason to suspect they re infected. And that s the point. When COVID-19 case counts fall, doctors and public health officials say the importance of finding and isolating asymptomatic carriers will re-emerge as a top priority for ending the pandemic. An analysis published last month in JAMA Network Open estimated more than half of all COVID-19 transmission originates in people who don t know they are infected.

United statesAl iskandariyahMacalester collegeUnited kingdomUniversity of minnesotaPrem premsrirutKenny beckmanWeyerhaeuser hallAtul gawandeTim walzTheresa adamsPaul overvoordeJoe carlsonCenters for diseaseMinnesota health departmentArizona state university